Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > on the news re: full creditor repayment
View:
Post by renaldo778 on Feb 20, 2022 4:10pm

on the news re: full creditor repayment

could it be a sign of a deal coming where they wanted the creditor out so they could now have full control of the 4050 i.p. ( 4050 was colateral ).

maybe im wrong... but logically, 39M$ is a lot of money paid back, there has to be a reason or a plan here, or a deal incoming that will benefit this plan of action.

  • Total interest savings of CA$9.1M
  • Immediate termination of Loan Agreement and release of security interests over all of its secured assets, including Intellectual Property
  • Immediate termination of Royalty Stream Agreement entered with Structured Alpha LP
  • Immediate cancellation of all Warrants issued pursuant to the Restructuring Agreement
  • Immediate release from all covenants under the Loan and Warrant Agreements

LAVAL, QC and CAMBRIDGE, England, Feb. 16, 2022 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced today that it has repaid its debt of $39.1 million to Structured Alpha LP ("SALP") in full, using cash on hand. The loan repayment terminates the Company's creditor relationship with SALP.

Comment by renaldo778 on Feb 21, 2022 4:57am
the way i read it, something is in the works and they need the i.p. back in company's control... this company just paid back 39 million$, thats a lot of research time to produce molecules/products to sell, they can only do this move if they have a deal incoming. I see a partnership with a major....   ======================================================================   ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities